Efficacy and safety of bioactive glass s53p4 as a treatment for diabetic foot osteomyelitis

The objective of the study was to test the efficacy and safety of BG in treating diabetic foot osteomyelitis.This was an observational, retrospective, single-center study involving subjects with diabetes affected by osteomyelitis of the foot who underwent surgical debridement from 01/2016 to 10/2018.

Source: Journal of Foot and Ankle Surgery - September 4, 2020 Category: Orthopaedics Authors: R De Giglio, G Di Vieste, T Mondello, G Balduzzi, B Masserini, I Formenti, S Lodigiani, D Pallavicini, B Pintaudi, A Mazzone Tags: Original Research Source Type: research